1. Marine-Derived Secondary Metabolites as Promising Epigenetic Bio-Compounds for Anticancer Therapy
   Mariarosaria Conte et al, 2020, Marine Drugs CrossRef
2. Clear cell sarcoma: state-of-the art and perspectives
   Laureline Wetterwald et al, 2023, Expert Review of Anticancer Therapy CrossRef
3. 当科における進行軟部肉腫に対するエリブリンの使用経験
   悠太 久保田 et al, 2022, Orthopedics & Traumatology CrossRef
4. Safety and effectiveness of eribulin in Japanese patients with soft tissue sarcoma including rare subtypes: a post-marketing observational study
   Akira Kawai et al, 2022, BMC Cancer CrossRef